drugset / Trial / NCT01991860
US Phase III Study of APD421 in PONV
RandomizedParallel-groupQuadruple-blindPrevention
Summary
A comparison of the efficacy of APD421 and placebo in the prevention of PONV in patients at moderate-to-high risk of PONV.
Timeline
- Start
- 2013-08
- Primary completion
- 2014-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amisulpride | Small molecule | 5 mg | Intravenous |
Indications
No indication recorded.